These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32889163)

  • 1. A Modiied 3-Way Tap to Enhance the Stability and Uniformity of Sclerosant Foam.
    Zhang H; Yang A; Xu M; Liu S
    Ann Vasc Surg; 2021 Jan; 70():501-505. PubMed ID: 32889163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Compound Sclerosant: Polidocanol-Bleomycin Foam.
    Hanshu Z; Shaohua L; Anwei C
    Dermatol Surg; 2020 Dec; 46(12):1712-1714. PubMed ID: 32769523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Pushing Rate on Foam Stability in the Tessari Method.
    Azmoun S; Liu Y; Bian K; Chen A; Liu S
    Dermatol Surg; 2024 Jun; 50(6):542-545. PubMed ID: 38460194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleomycin Polidocanol Foam (BPF) Stability - In Vitro Evidence for the Effectiveness of a Novel Sclerosant for Venous Malformations.
    Sun Y; Gu H; Yang X; Cai R; Shang Y; Hu L; Wang Y; Chen H; Lin X
    Eur J Vasc Endovasc Surg; 2020 Jun; 59(6):1011-1018. PubMed ID: 32063463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of foam in sclerotherapy: differences between sodium tetradecyl sulfate and polidocanol and the type of connector used in the double-syringe system technique.
    Rao J; Goldman MP
    Dermatol Surg; 2005 Jan; 31(1):19-22. PubMed ID: 15720090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of polidocanol foam in view of its use in sclerotherapy.
    Nastasa V; Samaras K; Ampatzidis Ch; Karapantsios TD; Trelles MA; Moreno-Moraga J; Smarandache A; Pascu ML
    Int J Pharm; 2015 Jan; 478(2):588-96. PubMed ID: 25433198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigation into the influence of various gases and concentrations of sclerosants on foam stability.
    Peterson JD; Goldman MP
    Dermatol Surg; 2011 Jan; 37(1):12-7. PubMed ID: 21199095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new method for using radiopaque sclerosing foam to treat venous malformations.
    Li K; Liu YR; Chen AW; Liu SH
    Dermatol Surg; 2015 Jun; 41(6):726-30. PubMed ID: 25973562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of environmental and compositional manipulations on the longevity of Tessari-made foam for sclerotherapy.
    Patel SB; Ostler AE; Dos Santos SJ; Piriea TM; Whiteley MS
    J Vasc Surg Venous Lymphat Disord; 2015 Jul; 3(3):312-8. PubMed ID: 26992311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of Sclerosing Foam Stability in the Treatment of Varicose Veins.
    Bai T; Liu Y; Jiang W; Li Y; Liu J; Yu C; Fan Y
    Dermatol Surg; 2020 Feb; 46(2):249-257. PubMed ID: 31569112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Investigation on the Influence of Hyaluronic Acid on Polidocanol Foam Stability.
    Chen AW; Liu YR; Li K; Liu SH
    Dermatol Surg; 2016 Jan; 42(1):56-8. PubMed ID: 26671207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polidocanol foam stability in terms of its association with glycerin.
    Rial R; Hervas LS; Monux G; Galindo A; Martin A; Hernando M; Martinez I; Hernando A; Serrano FJ
    Phlebology; 2014 Jun; 29(5):304-9. PubMed ID: 23470491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foams.
    Carugo D; Ankrett DN; Zhao X; Zhang X; Hill M; O'Byrne V; Hoad J; Arif M; Wright DD; Lewis AL
    Phlebology; 2016 May; 31(4):283-95. PubMed ID: 26036246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Stability of Physician-Compounded Foam is Influenced by the Angle of Connector.
    Shi X; Liu Y; Li D; Tursun M; Azmoun S; Liu S
    Ann Vasc Surg; 2024 Feb; 99():217-222. PubMed ID: 37852364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying the Most Stable State of a Foam Sclerosant for Foam Sclerotherapy.
    Zhang HS; Yang AJ; Liu S
    Dermatol Surg; 2020 Oct; 46(10):e66-e70. PubMed ID: 31895253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the relative silicone content of different syringes affect the stability of foam in sclerotherapy?
    Lai SW; Goldman MP
    J Drugs Dermatol; 2008 Apr; 7(4):399-400. PubMed ID: 18459524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel developments in foam sclerotherapy: Focus on Varithena® (polidocanol endovenous microfoam) in the management of varicose veins.
    Star P; Connor DE; Parsi K
    Phlebology; 2018 Apr; 33(3):150-162. PubMed ID: 28166694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified Tessari Tourbillon technique for making foam sclerotherapy with silicone-free syringes.
    Whiteley MS; Patel SB
    Phlebology; 2015 Oct; 30(9):614-7. PubMed ID: 25288590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified Tessari method for producing more foam.
    Xu J; Wang YF; Chen AW; Wang T; Liu SH
    Springerplus; 2016; 5():129. PubMed ID: 26933628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous disorders: treatment with sclerosant foam.
    Bergan J; Pascarella L; Mekenas L
    J Cardiovasc Surg (Torino); 2006 Feb; 47(1):9-18. PubMed ID: 16434941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.